Dr. Andrew Daly is a Clinical Associate Professor in the Cumming School of Medicine, University of Calgary. He completed his undergraduate and post-graduate (Internal Medicine and Hematology) medical training at McGill University and his Bone Marrow Transplant Fellowship at the University of Toronto. He is currently Head of the Section of Hematology at the University of Calgary and AHS Calgary Zone. He has held numerous leadership positions, including Medical Director of the Alberta Blood and Marrow Transplant Program (2011-2019) and Treasurer and President of the Canadian Bone Marrow Transplant Group (CBMTG).
Area of Focus
- Hematopoietic cell transplantation
Summary of Research
Dr. Daly’s research interests are in the area of hematopoietic cell transplantation and cellular therapy. He is Principal Investigator for a national study exploring the use of haploidentical stem cell donors in the Canadian context (CBMTG 1401) and a member of the Late Effects, Chronic Leukemia, Infection and GVHD working groups for the CIBMTR. He is an Expert Clinical Reviewer for the Canadian Agency for Drugs and Technologies in Healthcare (CADTH).
Selected publications
- Papanicolaou GA, Ustun C, Young JH, Chen M, Kim S, Woo Ahn K, Komanduri K, Lindemans C, Auletta JJ, Riches ML; CIBMTR® Infection and Immune Reconstitution Working Committee. Bloodstream Infection Due to Vancomycin-resistant Enterococcus in Associated with Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. Clin Infect Dis. 2019 Oct 30 69(10):1771-79
- Kareem Jamani MD*, Rosy Dabas MSc, Shahbal B. Kangarloo MSc, Nicole L. Prokopishyn PhD, Joanne Luider BSc, Poonam Dharmani-Khan PhD, Faisal M. Khan PhD, Andrew Daly MD & Jan Storek MD PhD. Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the Levels. BBMT 2019 Apr; 25(4): 639-47
- Tay, J., Daly, A., Jamani, K., Labelle, L., Savoie, L., Stewart, D., Storek, J., & Beattie, S. (2018). Patient Eligibility for Hematopoietic Stem Cell Transplantation: A Review of Patient-Associated Variables. Bone Marrow Transplantation (2019); 54: 368-82
- Sita Bhella, Navneet S Majhail, Jeffrey Betcher, Luciano J Costa, Andrew Daly, Christopher E Dandoy, Zachariah DeFilipp, Vi Doan, Alison Gulbis, Lisa Hicks, Mark Juckett, Nandita Khera, Amrita Krishnan, George Selby, Nirav N Shah, Melisa Stricherz, Auro Viswabandya, Christopher Bredeson, Matthew D Seftel. Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group’s List of Five Tests and Treatments to Questions in Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2018; 24(5):909-13
Area Of Focus
- Hematopoietic cell transplantation
Summary Of Research
Dr. Daly’s research interests are in the area of hematopoietic cell transplantation and cellular therapy. He is Principal Investigator for a national study exploring the use of haploidentical stem cell donors in the Canadian context (CBMTG 1401) and a member of the Late Effects, Chronic Leukemia, Infection and GVHD working groups for the CIBMTR. He is an Expert Clinical Reviewer for the Canadian Agency for Drugs and Technologies in Healthcare (CADTH).
Selected publications
- Papanicolaou GA, Ustun C, Young JH, Chen M, Kim S, Woo Ahn K, Komanduri K, Lindemans C, Auletta JJ, Riches ML; CIBMTR® Infection and Immune Reconstitution Working Committee. Bloodstream Infection Due to Vancomycin-resistant Enterococcus in Associated with Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. Clin Infect Dis. 2019 Oct 30 69(10):1771-79
- Kareem Jamani MD*, Rosy Dabas MSc, Shahbal B. Kangarloo MSc, Nicole L. Prokopishyn PhD, Joanne Luider BSc, Poonam Dharmani-Khan PhD, Faisal M. Khan PhD, Andrew Daly MD & Jan Storek MD PhD. Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the Levels. BBMT 2019 Apr; 25(4): 639-47
- Tay, J., Daly, A., Jamani, K., Labelle, L., Savoie, L., Stewart, D., Storek, J., & Beattie, S. (2018). Patient Eligibility for Hematopoietic Stem Cell Transplantation: A Review of Patient-Associated Variables. Bone Marrow Transplantation (2019); 54: 368-82
- Sita Bhella, Navneet S Majhail, Jeffrey Betcher, Luciano J Costa, Andrew Daly, Christopher E Dandoy, Zachariah DeFilipp, Vi Doan, Alison Gulbis, Lisa Hicks, Mark Juckett, Nandita Khera, Amrita Krishnan, George Selby, Nirav N Shah, Melisa Stricherz, Auro Viswabandya, Christopher Bredeson, Matthew D Seftel. Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group’s List of Five Tests and Treatments to Questions in Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2018; 24(5):909-13